Martin Shkreli Faces New Accusations Over High-Priced Drug

h s January 27, 2020

A lawsuit by the Federal Trade Commission and New York’s attorney general says his company blocked generic rivals after sharply raising the cost of Daraprim.

from Health https://ift.tt/30YYgMw